| Filed | As-Of/On | Form | Fullname | Fund Class | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypotheticals Return |
Hypotheticals Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
News Article |
History |
|---|
| 2009-11-18 | 2009-09-30 | 13F-HR | Jane Street Holding Llc | Institution | 25,792 | Added More | 400 | 1.57 % | $260,499 | $251,988 | $-8,511 | -3.26 % | $-132 | | | | | | News Article | History of Jane Street Holding Llc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR/A | Amvescap Plc | Institution | 849,161 | New Holding | 849,161 | 100 % | $8,771,833 | $8,296,303 | $-475,530 | -5.42 % | $-475,530 | | | | | | News Article | History of Amvescap Plc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR/A | Credit Suisse First Boston | Institution | | Sold All | -64,186 | -100 % | | | | -5.42 % | $35,944 | | | | | | News Article | History of Credit Suisse First Boston Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | American International Group Inc | Institution | 28,007 | No Change | 0 | 0 % | $308,917 | $273,628 | $-35,289 | -11.42 % | $0 | | | | | | News Article | History of American International Group Inc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Black River Asset Management Llc | Institution | 15,400 | New Holding | 15,400 | 100 % | $169,862 | $150,458 | $-19,404 | -11.42 % | $-19,404 | | | | | | News Article | History of Black River Asset Management Llc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Bridger Management Llc | Institution | 346,550 | New Holding | 346,550 | 100 % | $3,822,447 | $3,385,794 | $-436,653 | -11.42 % | $-436,653 | | | | | | News Article | History of Bridger Management Llc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Citadel L P | Institution | 336,376 | New Holding | 336,376 | 100 % | $3,710,227 | $3,286,394 | $-423,834 | -11.42 % | $-423,834 | | | | | | News Article | History of Citadel L P Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Dafna Capital Management Llc | Institution | 101,402 | Sold Some | -234,998 | -69.85 % | $1,118,464 | $990,698 | $-127,767 | -11.42 % | $296,097 | | | | | | News Article | History of Dafna Capital Management Llc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Driehaus Capital Management Llc | Institution | 158,230 | New Holding | 158,230 | 100 % | $1,745,277 | $1,545,907 | $-199,370 | -11.42 % | $-199,370 | | | | | | News Article | History of Driehaus Capital Management Llc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Fmr Corp | Institution | 402,155 | New Holding | 402,155 | 100 % | $4,435,770 | $3,929,054 | $-506,715 | -11.42 % | $-506,715 | | | | | | News Article | History of Fmr Corp Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Galleon Management L P | Institution | 30,000 | New Holding | 30,000 | 100 % | $330,900 | $293,100 | $-37,800 | -11.42 % | $-37,800 | | | | | | News Article | History of Galleon Management L P Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Ing Groep Nv | Institution | 13,250 | Added More | 2,950 | 28.64 % | $146,148 | $129,453 | $-16,695 | -11.42 % | $-3,717 | | | | | | News Article | History of Ing Groep Nv Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Millennium Management Llc | Institution | 223,672 | Added More | 15,746 | 7.57 % | $2,467,102 | $2,185,275 | $-281,827 | -11.42 % | $-19,840 | | | | | | News Article | History of Millennium Management Llc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Morgan Stanley | Institution | 50,156 | New Holding | 50,156 | 100 % | $553,221 | $490,024 | $-63,197 | -11.42 % | $-63,197 | | | | | | News Article | History of Morgan Stanley Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Northern Trust Corp | Institution | 394,154 | Added More | 240,074 | 155.81 % | $4,347,519 | $3,850,885 | $-496,634 | -11.42 % | $-302,493 | | | | | | News Article | History of Northern Trust Corp Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR/A | Oppenheimer Funds Inc | Institution | | Sold All | -4,170 | -100 % | | | | -11.42 % | $5,254 | | | | | | News Article | History of Oppenheimer Funds Inc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Palo Alto Investors Llc | Institution | 343,933 | Added More | 123,785 | 56.22 % | $3,793,581 | $3,360,225 | $-433,356 | -11.42 % | $-155,969 | | | | | | News Article | History of Palo Alto Investors Llc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Teleos Management Llc | Institution | 10,000 | New Holding | 10,000 | 100 % | $110,300 | $97,700 | $-12,600 | -11.42 % | $-12,600 | | | | | | News Article | History of Teleos Management Llc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Us Bancorp De | Institution | 2,512 | No Change | 0 | 0 % | $27,707 | $24,542 | $-3,165 | -11.42 % | $0 | | | | | | News Article | History of Us Bancorp De Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Wellington Management Co Llp | Institution | 76,850 | No Change | 0 | 0 % | $847,656 | $750,825 | $-96,831 | -11.42 % | $0 | | | | | | News Article | History of Wellington Management Co Llp Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Ameriprise Financial Inc | Institution | 2,000 | New Holding | 2,000 | 100 % | $21,420 | $19,540 | $-1,880 | -8.77 % | $-1,880 | | | | | | News Article | History of Ameriprise Financial Inc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Axa | Institution | 716,340 | Added More | 566,318 | 377.48 % | $7,672,001 | $6,998,642 | $-673,360 | -8.77 % | $-532,339 | | | | | | News Article | History of Axa Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Barclays Plc | Institution | 2,469 | Added More | 2,210 | 853.28 % | $26,443 | $24,122 | $-2,321 | -8.77 % | $-2,077 | | | | | | News Article | History of Barclays Plc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Bnp Paribas Arbitrage Sa | Institution | 12,126 | New Holding | 12,126 | 100 % | $129,869 | $118,471 | $-11,398 | -8.77 % | $-11,398 | | | | | | News Article | History of Bnp Paribas Arbitrage Sa Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Credit Agricole S A | Institution | 2,460 | New Holding | 2,460 | 100 % | $26,347 | $24,034 | $-2,312 | -8.77 % | $-2,312 | | | | | | News Article | History of Credit Agricole S A Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Dekabank Deutsche Girozentrale | No Data | 206,886 | No Change | 0 | 0 % | $2,215,749 | $2,021,276 | $-194,473 | -8.77 % | $0 | | | | | | News Article | History of Dekabank Deutsche Girozentrale Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Gartmore Mutual Fund Capital Trust | Institution | 292 | Sold Some | -27,018 | -98.93 % | $3,127 | $2,853 | $-274 | -8.77 % | $25,397 | | | | | | News Article | History of Gartmore Mutual Fund Capital Trust Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Goldman Sachs Group Inc | Institution | 14,084 | Added More | 2,186 | 18.37 % | $150,840 | $137,601 | $-13,239 | -8.77 % | $-2,055 | | | | | | News Article | History of Goldman Sachs Group Inc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Jacobs Levy Equity Management Inc | Institution | | Sold All | -26,510 | -100 % | | | | -8.77 % | $24,919 | | | | | | News Article | History of Jacobs Levy Equity Management Inc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Rbc Capital Markets Arbitrage S A | Institution | 600 | New Holding | 600 | 100 % | $6,426 | $5,862 | $-564 | -8.77 % | $-564 | | | | | | News Article | History of Rbc Capital Markets Arbitrage S A Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Rbc Dain Rauscher Inc | Institution | 26,176 | New Holding | 26,176 | 100 % | $280,345 | $255,740 | $-24,605 | -8.77 % | $-24,605 | | | | | | News Article | History of Rbc Dain Rauscher Inc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Renaissance Technologies Corp | Institution | | Sold All | -26,100 | -100 % | | | | -8.77 % | $24,534 | | | | | | News Article | History of Renaissance Technologies Corp Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Vanguard Group Inc | Institution | 31,579 | Added More | 1,400 | 4.63 % | $338,211 | $308,527 | $-29,684 | -8.77 % | $-1,316 | | | | | | News Article | History of Vanguard Group Inc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Barclays Global Investors Uk Holdings Ltd | Institution | 1,321,431 | Added More | 144,205 | 12.24 % | $13,544,668 | $12,910,381 | $-634,287 | -4.68 % | $-69,218 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR/A | Ing Investment Management Co | Institution | 13,050 | Added More | 2,750 | 26.69 % | $133,763 | $127,499 | $-6,264 | -4.68 % | $-1,320 | | | | | | News Article | History of Ing Investment Management Co Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Merrill Lynch And Co Inc | Institution | 200 | Sold Some | -5,750 | -96.63 % | $2,050 | $1,954 | $-96 | -4.68 % | $2,760 | | | | | | News Article | History of Merrill Lynch And Co Inc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Mfc Global Investment Management Usa Ltd | Institution | 29,870 | Added More | 2,224 | 8.04 % | $306,168 | $291,830 | $-14,338 | -4.68 % | $-1,068 | | | | | | News Article | History of Mfc Global Investment Management Usa Ltd Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Padco Advisors Ii Inc | Institution | 1,215 | Added More | 77 | 6.76 % | $12,454 | $11,871 | $-583 | -4.68 % | $-37 | | | | | | News Article | History of Padco Advisors Ii Inc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Padco Advisors Inc | Institution | 1,541 | Added More | 623 | 67.86 % | $15,795 | $15,056 | $-740 | -4.68 % | $-299 | | | | | | News Article | History of Padco Advisors Inc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Susquehanna International Group Llp | Institution | | Sold All | -163,193 | -100 % | | | | -4.68 % | $78,333 | | | | | | News Article | History of Susquehanna International Group Llp Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Technical Financial Services Llc | Institution | 92,458 | New Holding | 92,458 | 100 % | $947,695 | $903,315 | $-44,380 | -4.68 % | $-44,380 | | | | | | News Article | History of Technical Financial Services Llc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Alphabet Management Llc | No Data | 76,300 | Added More | 6,400 | 9.15 % | $910,259 | $745,451 | $-164,808 | -18.10 % | $-13,824 | | | | | | News Article | History of Alphabet Management Llc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | J P Morgan Chase And Co | Institution | 344,183 | Sold Some | -120,597 | -25.94 % | $4,106,103 | $3,362,668 | $-743,435 | -18.10 % | $260,490 | | | | | | News Article | History of J P Morgan Chase And Co Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Ubs Ag | Institution | 1,370 | New Holding | 1,370 | 100 % | $16,344 | $13,385 | $-2,959 | -18.10 % | $-2,959 | | | | | | News Article | History of Ubs Ag Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Federated Investors Inc | Institution | 1,857,283 | Sold Some | -248,575 | -11.80 % | $22,547,416 | $18,145,655 | $-4,401,761 | -19.52 % | $589,123 | | | | | | News Article | History of Federated Investors Inc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Numeric Investors Llc | Institution | 412,447 | New Holding | 412,447 | 100 % | $5,007,107 | $4,029,607 | $-977,499 | -19.52 % | $-977,499 | | | | | | News Article | History of Numeric Investors Llc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Metropolitan Life Insurance Co | Institution | 33,551 | No Change | 0 | 0 % | $393,218 | $327,793 | $-65,424 | -16.63 % | $0 | | | | | | News Article | History of Metropolitan Life Insurance Co Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Pnc Financial Services Group Inc | Institution | | Sold All | -589 | -100 % | | | | -16.63 % | $1,149 | | | | | | News Article | History of Pnc Financial Services Group Inc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Teachers Advisors Inc | Institution | 30,329 | No Change | 0 | 0 % | $355,456 | $296,314 | $-59,142 | -16.63 % | $0 | | | | | | News Article | History of Teachers Advisors Inc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Tiaa Cref Investment Management Llc | Institution | 309,953 | Added More | 90,000 | 40.91 % | $3,632,649 | $3,028,241 | $-604,408 | -16.63 % | $-175,500 | | | | | | News Article | History of Tiaa Cref Investment Management Llc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-06 | 2009-08-31 | N-CSR | Valic Co Ii - Small Cap Value Fund | Small-Cap Value | | Sold All | -37,400 | -100 % | | | | -16.63 % | $72,930 | | | | | | News Article | History of Valic Co Ii - Small Cap Value Fund Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Proshare Advisors Llc | Institution | | Sold All | -13,588 | -100 % | | | | -15.77 % | $24,866 | | | | | | News Article | History of Proshare Advisors Llc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-03 | 2009-09-30 | 13F-HR | Turner Investment Partners Inc | Institution | 59,280 | New Holding | 59,280 | 100 % | $635,482 | $579,166 | $-56,316 | -8.86 % | $-56,316 | | | | | | News Article | History of Turner Investment Partners Inc Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Fidelity Select Portfolios - Pharmaceuticals Portfolio | Health/Biotech | 3,000 | New Holding | 3,000 | 100 % | $31,290 | $29,310 | $-1,980 | -6.32 % | $-1,980 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Protalix Biotherapeutics Inc |
| 2009-10-30 | 2009-09-30 | 13F-HR | Oxford Asset Management | Institution | 40,711 | New Holding | 40,711 | 100 % | $385,940 | $397,746 | $11,806 | 3.05 % | $11,806 | | | | | | News Article | History of Oxford Asset Management Ownership Of Protalix Biotherapeutics Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Usaa Mutual Funds Trust - Cornerstone Strategy Fund | Specialty & Misc | 2,900 | Added More | 2,300 | 383.33 % | $27,956 | $28,333 | $377 | 1.34 % | $299 | | | | | | News Article | History of Usaa Mutual Funds Trust - Cornerstone Strategy Fund Ownership Of Protalix Biotherapeutics Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Usaa Mutual Funds Trust - Growth Fund | Multi-Cap Growth | | Sold All | -700 | -100 % | | | | 1.34 % | $-91 | | | | | | News Article | History of Usaa Mutual Funds Trust - Growth Fund Ownership Of Protalix Biotherapeutics Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Valic Co I - Small Cap Index Fund | Small-Cap Core | 28,007 | New Holding | 28,007 | 100 % | $269,987 | $273,628 | $3,641 | 1.34 % | $3,641 | | | | | | News Article | History of Valic Co I - Small Cap Index Fund Ownership Of Protalix Biotherapeutics Inc |
| 2009-10-27 | 2009-09-30 | 13F-HR | Essex Investment Management Co Llc | Institution | 3,938 | Sold Some | -2,269 | -36.55 % | $36,545 | $38,474 | $1,930 | 5.28 % | $-1,112 | | | | | | News Article | History of Essex Investment Management Co Llc Ownership Of Protalix Biotherapeutics Inc |
| 2009-10-23 | 2009-09-30 | 13F-HR | Magee Thomson Investment Partners Llc | Institution | 10,590 | New Holding | 10,590 | 100 % | $89,380 | $103,464 | $14,085 | 15.75 % | $14,085 | | | | | | News Article | History of Magee Thomson Investment Partners Llc Ownership Of Protalix Biotherapeutics Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Inc | No Data | | Sold All | -1,300 | -100 % | | | | 11.65 % | $-1,326 | | | | | | News Article | History of Blackrock Inc Ownership Of Protalix Biotherapeutics Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Investment Management Llc | Institution | 44,388 | Sold Some | -5,596 | -11.19 % | $388,395 | $433,671 | $45,276 | 11.65 % | $-5,708 | | | | | | News Article | History of Blackrock Investment Management Llc Ownership Of Protalix Biotherapeutics Inc |
| 2009-10-21 | 2009-09-30 | 13F-HR | Bank Of New York Mellon Corp | Institution | 73,571 | Sold Some | -8,779 | -10.66 % | $671,703 | $718,789 | $47,085 | 7.00 % | $-5,619 | | | | | | News Article | History of Bank Of New York Mellon Corp Ownership Of Protalix Biotherapeutics Inc |
| 2009-10-21 | 2009-09-30 | 13F-HR | State Board Of Administration Of Florida Retirement System | Institution | 17,048 | New Holding | 17,048 | 100 % | $155,648 | $166,559 | $10,911 | 7.00 % | $10,911 | | | | | | News Article | History of State Board Of Administration Of Florida Retirement System Ownership Of Protalix Biotherapeutics Inc |
| 2009-10-19 | 2009-09-30 | 13F-HR | Strs Ohio | Institution | 18,000 | Sold Some | -17,800 | -49.72 % | $170,640 | $175,860 | $5,220 | 3.05 % | $-5,162 | | | | | | News Article | History of Strs Ohio Ownership Of Protalix Biotherapeutics Inc |
| 2009-10-15 | 2009-09-30 | 13F-HR | Public Employees Retirement System Of Ohio | Institution | 42,201 | No Change | 0 | 0 % | $395,423 | $412,304 | $16,880 | 4.26 % | $0 | | | | | | News Article | History of Public Employees Retirement System Of Ohio Ownership Of Protalix Biotherapeutics Inc |
| 2009-10-08 | 2009-09-30 | 13F-HR | Rhumbline Advisers | Institution | 44,673 | Sold Some | -1,600 | -3.45 % | $408,311 | $436,455 | $28,144 | 6.89 % | $-1,008 | | | | | | News Article | History of Rhumbline Advisers Ownership Of Protalix Biotherapeutics Inc |
| 2009-10-02 | 2009-07-31 | N-CSR | Alliancebernstein Cap Fund Inc - Alliancebernstein Small Cap Growth Portfolio | Small-Cap Growth | 43,000 | New Holding | 43,000 | 100 % | $348,300 | $420,110 | $71,810 | 20.61 % | $71,810 | | | | | | News Article | History of Alliancebernstein Cap Fund Inc - Alliancebernstein Small Cap Growth Portfolio Ownership Of Protalix Biotherapeutics Inc |
| 2009-10-02 | 2009-07-31 | N-CSR | Usaa Mutual Funds Trust - Growth Fund | Multi-Cap Growth | 700 | New Holding | 700 | 100 % | $5,670 | $6,839 | $1,169 | 20.61 % | $1,169 | | | | | | News Article | History of Usaa Mutual Funds Trust - Growth Fund Ownership Of Protalix Biotherapeutics Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Massmutual Premier Funds - Massmutual Premier Main Street Small Cap Fund | Small-Cap Core | | Sold All | -100 | -100 % | | | | 20.17 % | $-164 | | | | | | News Article | History of Massmutual Premier Funds - Massmutual Premier Main Street Small Cap Fund Ownership Of Protalix Biotherapeutics Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Massmutual Premier Funds - Massmutual Premier Small Company Opportunities Fund | Small-Cap Core | | Sold All | -100 | -100 % | | | | 20.17 % | $-164 | | | | | | News Article | History of Massmutual Premier Funds - Massmutual Premier Small Company Opportunities Fund Ownership Of Protalix Biotherapeutics Inc |
| 2009-09-17 | 2009-07-31 | N-Q | Rydex Etf Trust - Rydex Inverse Russell 2000 Etf | Specialty & Misc | 740 | New Holding | 740 | 100 % | $5,402 | $7,230 | $1,828 | 33.83 % | $1,828 | | | | | | News Article | History of Rydex Etf Trust - Rydex Inverse Russell 2000 Etf Ownership Of Protalix Biotherapeutics Inc |
| 2009-09-11 | 2009-06-30 | 13F-HR/A | Barclays Global Investors Uk Holdings Ltd | Institution | 1,177,226 | Added More | 856,208 | 266.71 % | $8,664,383 | $11,501,498 | $2,837,115 | 32.74 % | $2,063,461 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Protalix Biotherapeutics Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Rydex Series Funds - Banking Fund | Financial Services | 918 | Added More | 587 | 177.34 % | $6,968 | $8,969 | $2,001 | 28.72 % | $1,280 | | | | | | News Article | History of Rydex Series Funds - Banking Fund Ownership Of Protalix Biotherapeutics Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Rydex Variable Trust - Biotechnology Fund | Health/Biotech | 448 | Added More | 358 | 397.77 % | $3,400 | $4,377 | $977 | 28.72 % | $780 | | | | | | News Article | History of Rydex Variable Trust - Biotechnology Fund Ownership Of Protalix Biotherapeutics Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Advanced Series Trust - Ast Federated Aggressive Growth Portfolio | Multi-Cap Growth | | Sold All | -75,427 | -100 % | | | | 32.38 % | $-180,271 | | | | | | News Article | History of Advanced Series Trust - Ast Federated Aggressive Growth Portfolio Ownership Of Protalix Biotherapeutics Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Advanced Series Trust - Ast International Value Portfolio | Multi-Cap Value | | Sold All | -10,800 | -100 % | | | | 32.38 % | $-25,812 | | | | | | News Article | History of Advanced Series Trust - Ast International Value Portfolio Ownership Of Protalix Biotherapeutics Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Axa Premier Vip Trust - Multimanager Small Cap Growth Portfolio | Small-Cap Growth | | Sold All | -7,500 | -100 % | | | | 32.38 % | $-17,925 | | | | | | News Article | History of Axa Premier Vip Trust - Multimanager Small Cap Growth Portfolio Ownership Of Protalix Biotherapeutics Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqalliancebernstein Small Cap Growth Portfolio | Small-Cap Growth | 40,900 | No Change | 0 | 0 % | $301,842 | $399,593 | $97,751 | 32.38 % | $0 | | | | | | News Article | History of Eq Advisors Trust - Eqalliancebernstein Small Cap Growth Portfolio Ownership Of Protalix Biotherapeutics Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqalliancebernstein Value Portfolio | Multi-Cap Value | 5,800 | New Holding | 5,800 | 100 % | $42,804 | $56,666 | $13,862 | 32.38 % | $13,862 | | | | | | News Article | History of Eq Advisors Trust - Eqalliancebernstein Value Portfolio Ownership Of Protalix Biotherapeutics Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqbond Index Portfolio | Specialty & Misc | 99,922 | Sold Some | -19,178 | -16.10 % | $737,424 | $976,238 | $238,814 | 32.38 % | $-45,835 | | | | | | News Article | History of Eq Advisors Trust - Eqbond Index Portfolio Ownership Of Protalix Biotherapeutics Inc |
| 2009-09-04 | 2009-06-30 | N-CSR | Jpmorgan Trust I - Jpmorgan Japan Fund | Japanese | | Sold All | -31 | -100 % | | | | 32.38 % | $-74 | | | | | | News Article | History of Jpmorgan Trust I - Jpmorgan Japan Fund Ownership Of Protalix Biotherapeutics Inc |
| 2009-09-04 | 2009-06-30 | N-CSR | Jpmorgan Trust I - Jpmorgan Small Cap Core Fund | Small-Cap Core | | Sold All | -114 | -100 % | | | | 32.38 % | $-272 | | | | | | News Article | History of Jpmorgan Trust I - Jpmorgan Small Cap Core Fund Ownership Of Protalix Biotherapeutics Inc |
| 2009-09-04 | 2009-06-30 | N-CSR | Jpmorgan Trust Ii - Jpmorgan Small Cap Value Fund | Small-Cap Value | | Sold All | -51 | -100 % | | | | 32.38 % | $-122 | | | | | | News Article | History of Jpmorgan Trust Ii - Jpmorgan Small Cap Value Fund Ownership Of Protalix Biotherapeutics Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Sun Capital Advisers Trust - Sc Oppenheimer Main Street Small Cap Fund | Small-Cap Core | 160 | New Holding | 160 | 100 % | $1,181 | $1,563 | $382 | 32.38 % | $382 | | | | | | News Article | History of Sun Capital Advisers Trust - Sc Oppenheimer Main Street Small Cap Fund Ownership Of Protalix Biotherapeutics Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Mml Series Investment Fund Ii - Mml Small Cap Equity Fund | Small-Cap Core | 100 | New Holding | 100 | 100 % | $757 | $977 | $220 | 29.06 % | $220 | | | | | | News Article | History of Mml Series Investment Fund Ii - Mml Small Cap Equity Fund Ownership Of Protalix Biotherapeutics Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Pacific Select Fund - Pd Small-Cap Growth Index Portfolio | No Data | 559 | No Compare | | | $4,232 | $5,461 | $1,230 | 29.06 % | | | | | | | News Article | History of Pacific Select Fund - Pd Small-Cap Growth Index Portfolio Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Tiaa Cref Life Fund - Stock Index Fund | Specialty & Misc | 431 | New Holding | 431 | 100 % | $2,758 | $4,211 | $1,452 | 52.65 % | $1,452 | | | | | | News Article | History of Tiaa Cref Life Fund - Stock Index Fund Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-28 | 2009-06-30 | N-CSR | Allianz Funds - Occ Value | Large-Cap Value | 53,545 | Sold Some | -123,895 | -69.82 % | $320,199 | $523,135 | $202,936 | 63.37 % | $-469,562 | | | | | | News Article | History of Allianz Funds - Occ Value Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 2000 Growth Index Fund | Multi-Cap Growth | 247,943 | Added More | 176,847 | 248.74 % | $1,482,699 | $2,422,403 | $939,704 | 63.37 % | $670,250 | | | | | | News Article | History of Ishares Trust - Ishares Russell 2000 Growth Index Fund Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 2000 Index Fund | Specialty & Misc | 423,354 | Added More | 293,436 | 225.86 % | $2,531,657 | $4,136,169 | $1,604,512 | 63.37 % | $1,112,122 | | | | | | News Article | History of Ishares Trust - Ishares Russell 2000 Index Fund Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 3000 Growth Index Fund | Multi-Cap Growth | 2,181 | Added More | 1,100 | 101.75 % | $13,042 | $21,308 | $8,266 | 63.37 % | $4,169 | | | | | | News Article | History of Ishares Trust - Ishares Russell 3000 Growth Index Fund Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 3000 Index Fund | Specialty & Misc | 8,637 | Added More | 7,930 | 1121.64 % | $51,649 | $84,383 | $32,734 | 63.37 % | $30,055 | | | | | | News Article | History of Ishares Trust - Ishares Russell 3000 Index Fund Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell Microcap Index Fund | Specialty & Misc | 54,443 | New Holding | 54,443 | 100 % | $325,569 | $531,908 | $206,339 | 63.37 % | $206,339 | | | | | | News Article | History of Ishares Trust - Ishares Russell Microcap Index Fund Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds - Equity Index Fund | Specialty & Misc | 23,338 | Added More | 20,670 | 774.73 % | $141,428 | $228,012 | $86,584 | 61.22 % | $76,686 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds - Equity Index Fund Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds - Growth Equity Fund | Multi-Cap Growth | | Sold All | -4,567 | -100 % | | | | 61.22 % | $-16,944 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds - Growth Equity Fund Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-24 | 2009-06-30 | N-CSRS | Oppenheimer Variable Account Funds - Oppenheimer Main Street Fundva | Specialty & Misc | 700 | New Holding | 700 | 100 % | $4,186 | $6,839 | $2,653 | 63.37 % | $2,653 | | | | | | News Article | History of Oppenheimer Variable Account Funds - Oppenheimer Main Street Fundva Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-21 | 4 | Frost Gamma Investment Trust | Insider | 8,516,913 | Sold Some | -2,100 | -0.02 % | $51,697,662 | $83,210,240 | $31,512,578 | 60.95 % | $-7,770 | | | X | | | News Article | History of Frost Gamma Investment Trust Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-21 | 4 | Frost Gamma Investment Trust | Insider | 8,531,213 | Sold Some | -700 | 0.00 % | $51,784,463 | $83,349,951 | $31,565,488 | 60.95 % | $-2,590 | | | X | | | News Article | History of Frost Gamma Investment Trust Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-21 | 4 | Frost Gamma Investment Trust | Insider | 8,519,013 | Sold Some | -12,200 | -0.14 % | $51,710,409 | $83,230,757 | $31,520,348 | 60.95 % | $-45,140 | | | X | | | News Article | History of Frost Gamma Investment Trust Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-21 | 4 | Frost Phillip Md Et Al | Insider | 8,516,913 | Sold Some | -2,100 | -0.02 % | $51,697,662 | $83,210,240 | $31,512,578 | 60.95 % | $-7,770 | | | X | | | News Article | History of Frost Phillip Md Et Al Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-21 | 4 | Frost Phillip Md Et Al | Insider | 8,531,213 | Sold Some | -700 | 0.00 % | $51,784,463 | $83,349,951 | $31,565,488 | 60.95 % | $-2,590 | | | X | | | News Article | History of Frost Phillip Md Et Al Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-21 | 4 | Frost Phillip Md Et Al | Insider | 8,519,013 | Sold Some | -12,200 | -0.14 % | $51,710,409 | $83,230,757 | $31,520,348 | 60.95 % | $-45,140 | | | X | | | News Article | History of Frost Phillip Md Et Al Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-20 | 4 | Frost Gamma Investment Trust | Insider | 8,538,095 | Sold Some | -4,280 | -0.05 % | $51,826,237 | $83,417,188 | $31,590,952 | 60.95 % | $-15,836 | | | X | | | News Article | History of Frost Gamma Investment Trust Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-20 | 4 | Frost Gamma Investment Trust | Insider | 8,531,913 | Sold Some | -6,182 | -0.07 % | $51,788,712 | $83,356,790 | $31,568,078 | 60.95 % | $-22,873 | | | X | | | News Article | History of Frost Gamma Investment Trust Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-20 | 4 | Frost Gamma Investment Trust | Insider | 8,628,455 | Sold Some | -3,458 | -0.04 % | $52,374,722 | $84,300,005 | $31,925,284 | 60.95 % | $-12,795 | | | X | | | News Article | History of Frost Gamma Investment Trust Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-20 | 4 | Frost Gamma Investment Trust | Insider | 8,596,634 | Sold Some | -31,821 | -0.36 % | $52,181,568 | $83,989,114 | $31,807,546 | 60.95 % | $-117,738 | | | X | | | News Article | History of Frost Gamma Investment Trust Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-20 | 4 | Frost Gamma Investment Trust | Insider | 8,595,906 | Sold Some | -728 | 0.00 % | $52,177,149 | $83,982,002 | $31,804,852 | 60.95 % | $-2,694 | | | X | | | News Article | History of Frost Gamma Investment Trust Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-20 | 4 | Frost Gamma Investment Trust | Insider | 8,591,356 | Sold Some | -4,550 | -0.05 % | $52,149,531 | $83,937,548 | $31,788,017 | 60.95 % | $-16,835 | | | X | | | News Article | History of Frost Gamma Investment Trust Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-20 | 4 | Frost Gamma Investment Trust | Insider | 8,545,325 | Sold Some | -46,031 | -0.53 % | $51,870,123 | $83,487,825 | $31,617,703 | 60.95 % | $-170,315 | | | X | | | News Article | History of Frost Gamma Investment Trust Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-20 | 4 | Frost Gamma Investment Trust | Insider | 8,542,466 | Sold Some | -2,859 | -0.03 % | $51,852,769 | $83,459,893 | $31,607,124 | 60.95 % | $-10,578 | | | X | | | News Article | History of Frost Gamma Investment Trust Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-20 | 4 | Frost Gamma Investment Trust | Insider | 8,542,375 | Sold Some | -91 | 0.00 % | $51,852,216 | $83,459,004 | $31,606,788 | 60.95 % | $-337 | | | X | | | News Article | History of Frost Gamma Investment Trust Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-20 | 4 | Frost Phillip Md Et Al | Insider | 8,596,634 | Sold Some | -31,821 | -0.36 % | $52,181,568 | $83,989,114 | $31,807,546 | 60.95 % | $-117,738 | | | X | | | News Article | History of Frost Phillip Md Et Al Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-20 | 4 | Frost Phillip Md Et Al | Insider | 8,628,455 | Sold Some | -3,458 | -0.04 % | $52,374,722 | $84,300,005 | $31,925,284 | 60.95 % | $-12,795 | | | X | | | News Article | History of Frost Phillip Md Et Al Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-20 | 4 | Frost Phillip Md Et Al | Insider | 8,545,325 | Sold Some | -46,031 | -0.53 % | $51,870,123 | $83,487,825 | $31,617,703 | 60.95 % | $-170,315 | | | X | | | News Article | History of Frost Phillip Md Et Al Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-20 | 4 | Frost Phillip Md Et Al | Insider | 8,542,466 | Sold Some | -2,859 | -0.03 % | $51,852,769 | $83,459,893 | $31,607,124 | 60.95 % | $-10,578 | | | X | | | News Article | History of Frost Phillip Md Et Al Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-20 | 4 | Frost Phillip Md Et Al | Insider | 8,542,375 | Sold Some | -91 | 0.00 % | $51,852,216 | $83,459,004 | $31,606,788 | 60.95 % | $-337 | | | X | | | News Article | History of Frost Phillip Md Et Al Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-20 | 4 | Frost Phillip Md Et Al | Insider | 8,538,095 | Sold Some | -4,280 | -0.05 % | $51,826,237 | $83,417,188 | $31,590,952 | 60.95 % | $-15,836 | | | X | | | News Article | History of Frost Phillip Md Et Al Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-20 | 4 | Frost Phillip Md Et Al | Insider | 8,531,913 | Sold Some | -6,182 | -0.07 % | $51,788,712 | $83,356,790 | $31,568,078 | 60.95 % | $-22,873 | | | X | | | News Article | History of Frost Phillip Md Et Al Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-20 | 4 | Frost Phillip Md Et Al | Insider | 8,591,356 | Sold Some | -4,550 | -0.05 % | $52,149,531 | $83,937,548 | $31,788,017 | 60.95 % | $-16,835 | | | X | | | News Article | History of Frost Phillip Md Et Al Ownership Of Protalix Biotherapeutics Inc |
| 2009-08-21 | 2009-08-20 | 4 | Frost Phillip Md Et Al | Insider | 8,595,906 | Sold Some | -728 | 0.00 % | $52,177,149 | $83,982,002 | $31,804,852 | 60.95 % | $-2,694 | | | X | | | News Article | History of Frost Phillip Md Et Al Ownership Of Protalix Biotherapeutics Inc |
RSS feed for PLX